GENE ONLINE|News &
Opinion
Blog

2019-11-05| China

2019 CSCO China, with highlights on proteomics-driven precision medicine, oncology treatment and quality control, and breakthroughs in drug developments

by GeneOnline
Share To
The 22nd annual installment of the Chinese Society of Clinical Oncology (CSCO) meeting, took place at the Xiamen International Conference Center on September 19, for 4 days. The theme of the 22nd conference was “Precision & Intelligence: Hope to conquer cancer”. The conference had four aims: (1) Encourage the exchange of new knowledge and technology in clinical oncology; (2) Promote scientific exchange between China and other countries; (3) Support academic research; (4) Support innovation in the industry. The conference attracted approximately 30,000 participants, more than 600 speakers and paper presenters from China and abroad, and 275 manufacturers from China. Geneonline attended the CSCO meeting, and reported the highlights of this conference.

GO Prime with only $1.49 now

LATEST
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
Illumina’s IVD Biomarker Test Becomes the First FDA-approved Pan-cancer Companion Diagnostics Kit
2024-09-11
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
EVENT
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top